Expand All | Collapse All
Marcy B. Bolster, MD, Chair
Dr. Bolster is an Associate Professor of Medicine at Harvard Medical School. She is the Director of the rheumatology fellowship training program in the Division of Rheumatology, Allergy and Immunology at the Massachusetts General Hospital (MGH). She is a board certified rheumatologist.
Prior to her position at MGH, she was a Professor of Medicine, Division of Rheumatology, at the Medical University of South Carolina (MUSC), where she was on faculty from 1993-2012. She also served as the Director of the rheumatology fellowship training program; the Medical Director of the Center for Osteoporosis and Bone Health and the Medical Director of Musculoskeletal Institute at MUSC.
She is a fellow of the American College of Physicians and of the American College of Rheumatology (ACR), a member of the International Society for Clinical Densitometry and a member of the American Society for Bone Mineral Research. She is Chair, ACR Committee on Training and Workforce (COTW). She has served as co-leader for the ACR in the ACGME Next Accreditation System. She is a member of both the ACR and the Rheumatology Research Foundation Boards of Directors. She has served on the American Board of Internal Medicine (ABIM) Rheumatology Board and is currently its Chair. She is also the Chair of the ABIM Rheumatology Board Exam Committee, serves as a member of the ABIM Council and is the incoming Chair of the ABIM Exam Chairs Committee. She is a member of the MGH Department of Medicine Education Council and Innovation in Education Committee. She previously served as the co-Chairperson for the ACR Rheumatology In-Training Examination and on the ACR COTW, chairing the Sub-Committee on Resident Education, spearheading the development of “Rheum2Learn,” an online internal medicine resident education tool for rheumatology.
She obtained a bachelor of arts degree in chemistry and her medical degree from Duke University. She trained in internal medicine at the Eastern Virginia Graduate School of Medicine and obtained rheumatology training at MUSC.
As of January 2017, Dr. Bolster reported the following external relationships:
Clinical research, with funding for clinical trial expenses, clinical research staff and salary support, paid to Brigham and Women's Hospital and Massachusetts General Hospital, from the following company:
- Eli Lilly & Co., to study the use of teriparatide in patients with rheumatoid arthritis to determine if it might help improve erosions.
Work funded by educational grants from industry, paid directly to Massachusetts General Hospital Rheumatology, from the following companies:
- AbbVie, providing partial salary support for a rheumatology fellow; funding is used solely for a fellow's salary support.
- Amgen, providing partial salary support for a rheumatology fellow through the Rheumatology Research Foundation; funding is used solely for a fellow's salary support.
Work as an author or editor for following companies, with compensation as listed:
- Elsevier, receiving compensation as an editor for a volume of Rheumatic Disease Clinics of North America: Corticosteroids.
- Merck Manual, receiving compensation as an author.
Michael J. Battistone, MD
Dr. Battistone, a board certified internist and rheumatologist, is Associate Professor (with tenure) of Medicine, in the Division of Rheumatology at the University of Utah. He is also the Director of the Center of Excellence in Musculoskeletal (MSK) Care and Education at the George E. Wahlen Veterans Affairs (VA) Medical Center in Salt Lake City, and co-Director of the National Musculoskeletal Training Programs at the VA Simulation, Learning, Education and Research Network (SimLEARN) in Orlando, Florida. He also supervises several internal medicine resident primary care clinics, and leads a multidisciplinary MSK clinic at the VA, which involves faculty from orthopedic, physical medicine and rehabilitation, and endocrinologic departments. Dr. Battistone is also the principal investigator at the Salt Lake City VA for the national Cooperative Studies Program STOP GOUT Trial.
Over the course of his career, he has served as the Director of the first, second and senior medical school courses in physical diagnosis; as Director of the core clerkship in internal medicine; and as Director of the rheumatology fellowship training program. He is a member of the American Board of Internal Medicine Rheumatology Board Exam Committee. Dr. Battistone has received numerous institutional teaching awards, as well as the national Clinician Scholar Educator award from the American College of Rheumatology Research Foundation.
Dr. Battistone received his medical degree from Duke University in 1991. He completed all of his postgraduate training at the University of Utah Health Sciences Center, which included internal medicine internship and residency, an additional year as chief medical resident, and a two-year fellowship in rheumatology.
As of January 2017, Dr. Battistone reported no external relationship.
Eliza Chakravarty, MD
Dr. Chakravarty is an Associate Member of the Oklahoma Medical Research Foundation, where she has an active clinical practice and a clinical research program focusing on pregnancy in women with autoimmune diseases. She is board certified in Rheumatology.
Previously, Dr. Chakravarty was an Assistant Professor of Medicine in the Division of Immunology at Stanford University School of Medicine in Palo Alto, California. During her time at Stanford, she served as Program Director for the Adult Rheumatology Fellowship program. Additionally, she served as an active member of the American College of Rheumatology Training and Workforce Committee. Currently, she serves as a member of the American Board of Internal Medicine Rheumatology Board Exam Committee.
Dr. Chakravarty received a bachelor's degree in chemistry and philosophy from New York University, a medical degree from the Johns Hopkins University and a master's degree in epidemiology from Stanford University. After completing internship, residency and Chief Residency in internal medicine at the Santa Clara Valley Medical Center in San Jose, California, she pursued fellowship training followed by an additional year of research training at Stanford University before joining the faculty in 2004.
As of January 2017, Dr. Chakravarty reported the following external relationships:
Funding for salary support, paid to Oklahoma Medical Research Foundation, from the following company:
- UCB, for an observational study of placental transfer of certolizomab in pregnant women with rheumatoid arthritis or Crohn's disease.
Service on data and safety monitoring boards for the following company, with honoraria:
- Dynavax, for a study of comparing hepatitis B vaccines.
Other compensation from not-for-profit healthcare–related organizations:
- Association of Reproductive Health Professionals, for development of content for a web-based didactic course on rheumatoid arthritis and women's health, receiving consulting fees.
- National Institutes of Health, for serving as chair of a data safety monitoring board for a trial of digatroban for systemic sclerosis, receiving consulting fees.
Jennifer M. Grossman, MD
Dr. Grossman is a Clinical Professor of Medicine in the Division of Rheumatology at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA). She is board certified in Rheumatology. She is also the Director of Lupus Clinical Research at UCLA and serves as the educational coordinator for rheumatology in the internal medicine residency training program.
Dr. Grossman is a member of the American Board of Internal Medicine Rheumatology Board Exam Committee. She is also a member of the American College of Rheumatology (ACR) and has served on the ACR Guidelines subcommittee. Dr. Grossman has been involved in quality of care measurements in osteoporosis and systemic lupus erythematosus. She is a member of the Lupus Foundation of America's scientific advisory board and is also a board member of Lupus LA.
Dr. Grossman received her bachelor's degree in chemistry from Williams College and her medical degree from the University of Rochester. She completed her internal medicine residency and rheumatology fellowship at the UCLA Center for the Health Sciences. She joined the faculty there in 1998.
As of April 2017, Dr. Grossman reported the following external relationships.
Funding for clinical trial expenses, salary support, and staff, paid to the University of California-Los Angeles, from the following companies:
- AstraZeneca, for a Phase 3 study of anifrilumab for lupus.
- Advanced Cell Technology, for two ophthalmology studies for dry macular degeneration and Stargardt's.
Dr. Grossman serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- Lupus Foundation of America, Scientific Advisory Board Member, receiving funding for development of a lupus disease activity measure, and reimbursement for travel.
- Medical Advisory Board for Lupus LA, Advisory Board Member, without compensation.
Hilary M. Haftel, MD
Dr. Haftel is board certified in Rheumatology and Pediatric Rheumatology. She is Professor of Pediatrics, Internal Medicine and Health Learning Sciences at the University of Michigan Medical School, where she has spent her entire academic career. She is Director of the Division of Pediatric Rheumatology and leads the Adolescent and Young Adult Rheumatology Program. She has been the Associate Chair and Director of Education in the Department of Pediatrics and Communicable Diseases at the University of Michigan since 2007, after serving as Assistant and then Associate Director of Pediatric Education for 11 years. Dr. Haftel served as Director of Communication Skills and Professionalism at the University of Michigan Medical School from 2003 to 2007.
Dr. Haftel is recognized nationally for her work in undergraduate and graduate medical education. She serves as a member of the American Board of Internal Medicine Rheumatology Board Exam Committee. She is a member of the Association for Pediatric Program Directors (APPD) Longitudinal Education Assessment Research Network (LEARN) Advisory Council and serves as its Chair. Dr. Haftel is Council Member of the APPD's Leadership in Educational Academic Development (LEAD) program. She has been named as a “Best Doctor in America” as well as being among “America's Best Pediatricians.”
Dr. Haftel received a bachelor's degree in biology and music from Union College in Schenectady, New York and a medical degree from Albany Medical College in Albany, New York, where she also completed residency training in combined medicine-pediatrics and a chief residency before coming to the University of Michigan for fellowship training in adult and pediatric rheumatology in 1991. Dr. Haftel received a master's of health professions education degree from the University of Illinois at Chicago in 2004.
As of January 2017, Dr. Haftel reported no external relationships.
Kevin M. McKown, MD
Dr. McKown, a board certified rheumatologist, is a Professor of Medicine at the University of Wisconsin School of Medicine and Public Health. He is Head of the Division of Rheumatology and Program Director of the Rheumatology Fellowship in the Department of Medicine.
Prior to his position at the University of Wisconsin School of Medicine and Public Health, he was an Associate Professor of Medicine, Division of Rheumatology at the University of Tennessee Health Science Center where he was on faculty from 1992 to 2000. At the University of Tennessee, he served as Associate Chairman for Graduate Programs in the Department of Medicine, Program Director of the Internal Medicine Residency Program, and co-Director of the Medicine-Neurology and Medicine-Pediatrics Residency Programs.
Dr. McKown is a member of the American Board of Internal Medicine Rheumatology Board Exam Committee. He is also a fellow of the American College of Physicians and the American College of Rheumatology, and is a member of the American Medical Association. He is currently a member of the Alliance for Academic Internal Medicine Association of Specialty Professors Council. Dr. McKown has been an active member of numerous medical education committees at the University of Wisconsin School of Medicine and Public Health and the University of Tennessee Health Sciences Center. His honors include the Alpha Omega Alpha Honor Medical Society, Best Doctors in America and several teaching awards from both the University of Wisconsin School of Medicine and Public Health and the University of Tennessee Health Sciences Center.
He obtained a bachelor's degree in physiology from Michigan State University and his medical degree from Wayne State University. He had one year of training in internal medicine at Wayne State University, before serving as a Primary Care Medical Officer in the United States Navy. He completed his internal medicine training and his rheumatology fellowship at the University of Tennessee Health Science Center.
As of January 2017, Dr. McKown reported no external relationships.
Kenneth S. O'Rourke, MD
Dr. O'Rourke, who is board certified in Internal Medicine and Rheumatology, is a Professor of Medicine at Wake Forest School of Medicine (WFSM). He is the Director of the Rheumatology Fellowship Training Program in the Section on Rheumatology and Immunology at WFSM (1995 to present).
Prior to his appointment at WFSM in 1992, Dr. O'Rourke was a Lecturer in the Rheumatology division of the Department of Internal Medicine at the University of Michigan (1991 to 1992). Prior to that position, he practiced general internal medicine in the United States Air Force (USAF) (1986 to 1989), and was the Program Director of the Transitional Year Residency at David Grant USAF Medical Center at Travis Air Force Base, California, while concurrently serving on the volunteer clinical faculty as Assistant Clinical Professor of Internal Medicine at the University of California, Davis (1987 to 1989).
Dr. O'Rourke is a fellow of the American College of Rheumatology (ACR) and member of the American College of Physicians. He is a member on the ACR's Curriculum Taskforce of the Committee on Education, and the Next Accreditation System Working Group of the Committee on Training and Workforce (COTW) that created the Rheumatology Entrustable Physician Activities and Rheumatology, Curricular Milestones. He currently serves as a member of the American Board of Internal Medicine Rheumatology Board Exam Committee. He is a founding member of the Carolinas Fellows Collaborative, whose work has included the creation of a competency-based curriculum of goals, objectives and linked evaluations for rheumatology fellowship training programs. At WFSM, he has served on numerous education committees, including as Director of the second-year Musculoskeletal Block of the Systems Pathophysiology Course.
Dr O'Rourke obtained a bachelor's degree in bioengineering from the University of California, Berkeley. He trained in internal medicine at the David Grant USAF Medical Center and rheumatology training at the University of Michigan Medical Center.
As of January 2017, Dr. O’Rourke reported the following external relationships:
Work as an author or editor for following companies, with compensation as listed:
- Section editor and chapter author for inPractice Rheumatology, an on-line textbook supported by pooled funding from Celgene and Genentech. Dr. Rourke receives honoraria for his contributions.
Mary C. Wasko, MD
Dr. Wasko is Division Director of Rheumatology for Allegheny Health Network. She is a professor for Temple University, Pittsburgh Campus. She maintains board certification in both Internal Medicine and Rheumatology.
Previously, Dr. Wasko served as a rheumatologist and Associate Professor of Medicine at the University of Pittsburgh, main campus.
Dr. Wasko served on the ACR Annual Meeting Planning Committee from 2011 to 2014. She has been a frequent lecturer for the Maintenance of Certification Course. Dr. Wasko is a member of the American Board of Internal Medicine Rheumatology Board Exam Committee. She was voted for Best Doctors in Pittsburgh list, 2012 to 2014, as well as voted Best Doctors in America, 2003 to 2014. She has fifteen years of external funding for investigator-initiated clinical research, serving as primary investigator and co-investigator on rheumatoid arthritis-related studies. Her work has resulted in more than 30 publications in peer-reviewed journals, including the New England Journal of Medicine, Arthritis and Rheumatology and the Journal of the American Medical Association.
Dr. Wasko received a bachelor's degree from Davidson College in North Carolina in 1979. She then received her medical degree from the University of North Carolina, School of Medicine, Chapel Hill in 1983. She further completed a master's degree in clinical research design and biostatistics from the University of Michigan School of Public Health in 1992.
As of January 2017, Dr. Wasko reported the following external relationships:
Funding for clinical trial expenses, staff and salary support, paid to the Allegheny Health Network, from the following companies:
- Amgen, for a withdrawal study in rheumatoid arthritis patients in remission on etanercept and methotrexate combination therapy.
- AstraZeneca, for a Phase 3 trial of anifrolumab in lupus.
- Bristol-Myers Squibb, to fund a study of investigational agent for the treatment of systemic lupus erythematosus.
- Human Genome Sciences, to fund an observational study to assess the side effects of belimumab in patients with lupus.
- UCB, to fund a clinical trial of epratuzumab, an investigational agent for the treatment of lupus.
Industry-supported continuing medical education supported by the following, with compensation for travel expenses and honoraria:
- Amgen, providing meals for Journal Club.
Funding for salary support, paid to the Allegheny Health Network, from the following companies:
- Defense Advanced Research Projects Agency, for fluorescent biosensor tattoos to monitor inflammation.